Rybelsus® 7 mg (Semaglutide) – Oral Tablets

Rybelsus® 7 mg (Semaglutide) – Oral Tablets

Once-Daily GLP-1 Receptor Agonist for Type 2 Diabetes

Rybelsus® 7 mg is a once-daily oral GLP-1 receptor agonist that helps lower blood sugar in adults with type 2 diabetes. It contains semaglutide, the same active ingredient as in Ozempic®, and is used after completing the 30-day starter dose of 3 mg.

This dosage is typically used as the first effective maintenance dose to improve HbA1c, support weight loss, and reduce cardiovascular risks when used along with diet and exercise.

✅ Key Benefits:

• Improves blood sugar control in type 2 diabetes

• Helps lower HbA1c and reduce fasting glucose levels

• May contribute to weight reduction

• Convenient oral tablet – no injections

• Taken once daily on an empty stomach

📦 Pack Sizes:

• 10 tablets –10 days supply

• Available only by prescription